Ken Griffin Legend Biotech Corp Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Legend Biotech Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 30,800 shares of LEGN stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,800

Previous 29,300 5.12%

Holding current value

$1.05 Million

Previous $1.43 Million 29.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$32.49 - $50.28 $51.6 Million - $79.9 Million	1,588,303 Added 120.64%	2,904,857 $94.5 Million
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $5.59 Million - $7.68 Million	-128,309 Reduced 8.88%	1,316,554 $64.2 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $11.9 Million - $17.2 Million	300,387 Added 26.25%	1,444,863 $64 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $53.9 Million - $68.5 Million	978,545 Added 589.73%	1,144,476 $64.2 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $8.27 Million - $10.1 Million	144,476 Added 673.39%	165,931 $9.98 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $1.1 Million - $1.33 Million	-17,357 Reduced 44.72%	21,455 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $1.46 Million - $2.36 Million	31,511 Added 431.6%	38,812 $2.68 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $1.05 Million - $1.39 Million	-24,192 Reduced 76.82%	7,301 $352,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $8.8 Million - $12.6 Million	-226,783 Reduced 87.81%	31,493 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $5.24 Million - $7.85 Million	137,467 Added 113.79%	258,276 $10.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $1.48 Million - $2.42 Million	44,044 Added 57.38%	120,809 $6.65 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $1.66 Million - $2.58 Million	53,585 Added 231.17%	76,765 $2.79 Million
Q4 2021 Feb 14, 2022	SELL	$41.14 - $56.98 $5.79 Million - $8.02 Million	-140,745 Reduced 85.86%	23,180 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $3.81 Million - $5.46 Million	107,964 Added 192.93%	163,925 $8.29 Million
Q2 2021 Aug 16, 2021	SELL	$25.8 - $41.09 $14 Million - $22.2 Million	-540,753 Reduced 90.62%	55,961 $2.3 Million
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $8.48 Million - $11.7 Million	360,065 Added 152.15%	596,714 $17.3 Million
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $1.77 Million - $2.22 Million	-68,527 Reduced 22.45%	236,649 $6.66 Million
Q3 2020 Nov 16, 2020	BUY	$27.5 - $39.61 $7.56 Million - $10.9 Million	274,817 Added 905.22%	305,176 $9.42 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $1.1 Million - $1.29 Million	30,359 New	30,359 $1.29 Million

Others Institutions Holding LEGN

# of Institutions

232

Shares Held

86.1M

Call Options Held

260K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.69B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account